NASDAQ: QTIQt Imaging Holdings Inc Stock
$6.72+0.73 (+12.19%)
Updated Mar 16, 2026
QTI Price
$6.72
Fair Value Price
-$3.52
Market Cap
$79.98M
52 Week Low
$1.52
52 Week High
$9.21
P/E
-3.52x
P/B
-8.81x
P/S
5.93x
PEG
N/A
Dividend Yield
N/A
Revenue
$11.50M
Earnings
-$19.51M
Gross Margin
50.8%
Operating Margin
-143.89%
Profit Margin
-169.7%
Debt to Equity
-2.34
Operating Cash Flow
-$7M
Beta
0.28
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
QTI Overview
GigCapital5, Inc. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets the intelligent automation sector. GigCapital5 was incorporated in 2021 and is based in Palo Alto, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine QTI's potential to beat the market
- QTI doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
QTI
RankedUnranked of 103
RankedUnranked of 103
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.87 | A | |
| $9.78 | A | |
| $27.30 | A |
Be the first to know about important QTI news, forecast changes, insider trades & much more!
QTI News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how QTI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
QTI ($6.72) is overvalued by 290.81% relative to our estimate of its Fair Value price of -$3.52 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
QTI ($6.72) is not significantly undervalued (290.81%) relative to our estimate of its Fair Value price of -$3.52 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
QTI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more QTI due diligence checks available for Premium users.
Valuation
QTI fair value
Fair Value of QTI stock based on Discounted Cash Flow (DCF)
Price
$6.72
Fair Value
-$3.52
Undervalued by
290.81%
QTI ($6.72) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
QTI ($6.72) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
QTI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
QTI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.52x
Industry
26.43x
Market
32.08x
QTI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-8.81x
Industry
3.43x
QTI's financial health
Profit margin
Revenue
$4.2M
Net Income
-$4.6M
Profit Margin
-108.7%
QTI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
QTI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$12.1M
Liabilities
$21.2M
Debt to equity
-2.34
QTI's short-term liabilities ($12.74M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
QTI's short-term assets ($11.29M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
QTI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
QTI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$878.8k
Investing
$0.0
Financing
$572.0k
QTI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
QTI vs Medical Device Stocks
Qt Imaging Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.